CGEN Q2'26 Earnings: EPS estimate is (0.08) USD
Compugen Ltd. (CGEN) is scheduled to report Q2’26 results on Aug. 3 before market open, with release at 7:00 AM ET. The consensus estimates cited for Q2’26 are revenue of $1.28 million and EPS of -$0.08. The article references the company’s financials page for details.
How this was made
The 30-second read
Why it matters
Traders can use the stated consensus revenue ($1.28M) and EPS (-$0.08) to frame whether the upcoming print is likely to surprise and how to position into the event.
Market read
This is an earnings timing and consensus-expectations preview that can inform event-driven positioning and options implied-volatility expectations.
What to watch
The preview lacks guidance details, cash/burn commentary, and any pipeline or trial updates, which are often the real drivers of post-earnings repricing.
Background
Compugen (CGEN) is set to announce Q2'26 results on Aug 03 at 7:00 AM ET (11:00 AM UTC).
Ticker impact
CGEN is scheduled to report Q2'26 results Aug 03 before the open, with consensus revenue of $1.28M and EPS of -$0.08.
Likely elevated pre-earnings volatility around Aug 03, with direction dependent on whether reported results beat or miss the -$0.08 EPS and $1.28M revenue expectations.
This is a forward-looking earnings preview with specific consensus numbers, which can drive positioning and implied volatility into the print, but it does not include any new post-release datapoint.
Market effects
Biotech/small-cap earnings calendar risk for oncology/biopharma names, but no sector-wide new information is disclosed.
Primarily US pre-market positioning around a single small-cap earnings event.
Limited, as the article is company-specific and does not cite global regulatory or macro catalysts.
Counterpoint
Negative consensus EPS does not guarantee downside; if expectations are already low, a modest beat could still trigger a relief rally.
Key entities
- public_companyCGEN
Compugen Ltd., scheduled to report Q2'26 results before market open on Aug 03.